| Title: |
Efficacy of SARS-CoV-2 Vaccination in Dialysis Patients: Epidemiological Analysis and Evaluation of the Clinical Progress. |
| Authors: |
Mosconi, Giovanni, Fantini, Michela, Righini, Matteo, Flachi, Marta, Semprini, Simona, Hu, Lilio, Chiappo, Francesca, Veterani, Barbara, Ambri, Katia, Ferrini, Franca, Milanesi, Catia, Giudicissi, Antonio, La Manna, Gaetano, Rigotti, Angelo, Buscaroli, Andrea, Sambri, Vittorio, Cappuccilli, Maria |
| Source: |
Journal of Clinical Medicine; Aug2022, Vol. 11 Issue 16, p4723-N.PAG, 14p |
| Subject Terms: |
HEMODIALYSIS patients, SARS-CoV-2 Omicron variant, SARS-CoV-2, VACCINATION status, VACCINE effectiveness |
| Abstract: |
This study investigated the impact of the fourth COVID-19 pandemic wave on dialysis patients of Romagna territory, assessing the associations of vaccination status with infection risk, clinical severity and mortality. From November 2021 to February 2022, an epidemiological search was conducted on 829 patients under dialysis treatment for at least one month. The data were then analyzed with reference to the general population of the same area. A temporal comparison was also carried out with the previous pandemic waves (from March 2020 to October 2021). The epidemiological evolution over time in the dialysis population and in Romagna citizens replicated the global trend, as the peak of the fourth wave corresponded to the time of maximum diffusion of omicron variant (B.1.1.529). Of 771 prevalent dialysis patients at the beginning of the study, 109 (14.1%) contracted SARS-CoV-2 infection during the 4-month observation period. Vaccine adherence in the dialysis population of the reference area was above 95%. Compared to fully or partially vaccinated subjects, the unvaccinated ones showed a significantly higher proportion of infections (12.5% vs. 27.0% p = 0.0341), a more frequent need for hospitalization (22.2% vs. 50.0%) and a 3.3-fold increased mortality risk. These findings confirm the effectiveness of COVID-19 vaccines in keeping infectious risk under control and ameliorating clinical outcomes in immunocompromised patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
